
0:39
A short explanatory excerpt by Dr. Charles Mok about why identical active drugs can be marketed under different brand names and indications. Using examples (semaglutide/Ozempic for diabetes and tirzepatide/Mounjaro), the speaker explains manufacturers assign different names/indications so prescriptions reflect coverage: insurers often cover diabetes indications but not weight-loss, so the name/indication affects whether insurance pays.










